The silencing of has-miR-218-5p, an endogenous MBNL1/2 repressor in human myotubes, overexpressed in DM1 animal disease models and patient muscle biopsies also led to MBNL1/2 upregulation in myotubes [73]. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.